| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/08/2004 | WO2004056370A1 Use of a fatty acid composition for treatment of male infertility |
| 07/08/2004 | WO2004056334A1 Bath additives containing the dead sea salt, bicarbonate and silica |
| 07/08/2004 | WO2004056186A1 Cell-based vegf delivery |
| 07/08/2004 | WO2004042039B1 Induction of ctla-4 upregulation in t lymphocytes |
| 07/08/2004 | WO2004041071A3 Compositions, systems, and methods for focusing a cell-mediated immune response |
| 07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
| 07/08/2004 | WO2004035072A3 Identifying and treating vaginal infections |
| 07/08/2004 | WO2004021995A3 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 07/08/2004 | WO2004011621A3 Multi-step method for the differentiation of insulin positive, glucose |
| 07/08/2004 | WO2004009767A3 Cell therapy for regeneration |
| 07/08/2004 | WO2003101399A3 Novel bacterium for treatment of disease |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003078567B1 Methods of inducing differentiation in ex vivo expanded stem cells |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040132918 Resins based on polystyrene functionalisedmethyl esters groups of l-tyrosine and their uses |
| 07/08/2004 | US20040132674 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/08/2004 | US20040132656 Blood-coagulation factor VIII (or antihemophilic factor) containing trehalose stabilizer in absence of albumin; reconstitution with water |
| 07/08/2004 | US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 07/08/2004 | US20040132185 Cd8alphadendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 07/08/2004 | US20040132184 Three dimensional biological scaffold comprising myocytes for culturing and propagating heart muscle tissue; tissue directed therapy and heart models |
| 07/08/2004 | US20040132183 Converting nonhormone producing pancreatic cells into pancreatic stem cell which produce insulin and glucagon; diabetes prevention and treatment |
| 07/08/2004 | US20040132179 Treatment of t cell disorders |
| 07/08/2004 | US20040132121 Method of identifying antibacterial compounds |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132007 Modified virus |
| 07/08/2004 | US20040131707 an aqueous Soma, comprising apple cider vinegar, quinine, blackstrap molasses, sulfur, and whole milk; suited for treating lymphoid malignancies |
| 07/08/2004 | US20040131706 Pharmaceutical preparation |
| 07/08/2004 | US20040131694 Mixture of polysaccharides, thymus and prostate extract, carbohydrates in solvent; freezing, storage |
| 07/08/2004 | US20040131693 Topical applying |
| 07/08/2004 | US20040131644 Using phosphatides from poultry embryos |
| 07/08/2004 | US20040131632 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/08/2004 | US20040131630 Administering a attenuated bacteria ; nucleic acids; induce immunology response |
| 07/08/2004 | US20040131601 Injection of bone marrow-derived cells and medium for angiogenesis |
| 07/08/2004 | US20040131599 Fas ligand expressing hematopoietic cells for transplantation |
| 07/08/2004 | US20040131598 Cancer therapy |
| 07/08/2004 | US20040131596 Method and compositions for modifying target receptor function associated with neurological disorders |
| 07/08/2004 | US20040131595 Treating carcinoid neoplasms with therapeutic viruses |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/08/2004 | US20040131590 Anticancer agents |
| 07/08/2004 | US20040131587 Administering mixture of dendritic cells, apoptosis or necrosis agents,chemattractants |
| 07/08/2004 | US20040131585 Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 07/08/2004 | DE19751907B4 Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor Escherichia coli strain DSM 6601 for the treatment of diarrhea in the veterinary sector |
| 07/08/2004 | DE10259825A1 Ausleitungsbad Ausleitungsbad |
| 07/08/2004 | DE10259617A1 Treating tissue or cells intended for transplantation, with antimitotic agent to eliminate cells, especially pluri- or multi-potent cells, that are capable of proliferation |
| 07/08/2004 | DE10221411B4 Rekombinantes Fowlpox-Virus Recombinant fowlpox virus |
| 07/08/2004 | CA2510459A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | CA2505213A1 Cell-based vegf delivery |
| 07/07/2004 | EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 07/07/2004 | EP1434856A2 Activation and expansion of cells |
| 07/07/2004 | EP1434855A2 Adipose-derived stem cells and lattices |
| 07/07/2004 | EP1434790A1 Calcium-influx inhibitory factor and method of isolation thereof |
| 07/07/2004 | EP1434597A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/07/2004 | EP1434591A1 Use of fly larvae extracts for the treatment of wounds |
| 07/07/2004 | EP1434590A2 Method for inhibiting the formation of seromas using factor xiii |
| 07/07/2004 | EP1434586A1 Estrogen/gestagen combination preparation and application thereof |
| 07/07/2004 | EP1434569A1 Therapeutic biological product and method for formation of new vascularised bone |
| 07/07/2004 | EP1339356A4 Tissue-engineered vascular structures |
| 07/07/2004 | EP1222251A4 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/07/2004 | EP1212093B1 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 07/07/2004 | CN1511193A Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1509740A Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof |
| 07/07/2004 | CN1509725A Oral staphylococcus aureus filtrate preparation for improving immune function |
| 07/07/2004 | CN1509724A Propolis and preparing method thereof |
| 07/07/2004 | CN1156305C Chinese-medical oinment for treating burn |
| 07/07/2004 | CN1156304C Medicine for external application for curing diseases of digestive tract, repersussion and stopping pain and its preparation method |
| 07/07/2004 | CN1156303C Exterior-applied medicine for treating hyperosteogeny and lumbar intervertebral disk protrusion and preparation process thereof |
| 07/07/2004 | CN1156298C Tumor-eliminating ointment and preparation process |
| 07/07/2004 | CN1156297C Medicine for treating hepatitis B |
| 07/07/2004 | CN1156296C Oral liquid containing calcium |
| 07/07/2004 | CN1156295C Arthralgia eliminating medicine with function of dredging meridian passage |
| 07/07/2004 | CN1156292C Medicine for curing cholecystitis and its preparing method |
| 07/07/2004 | CN1156291C Mihaigao made of honey and its preparation |
| 07/07/2004 | CN1156290C Medicine for curing lupus erythematosus brain disease |
| 07/07/2004 | CN1156288C External application medicine for treating compression fracture |
| 07/07/2004 | CN1156287C Composite medicine for treating myocardosis |
| 07/07/2004 | CN1156286C Chinese medicine for treating disease and improving intelligence |
| 07/07/2004 | CN1156285C Medical wine for treating rheumatism, rheumatoid disease and phperosteogeny |
| 07/07/2004 | CN1156284C Chinese Medicine for treating hepatism |
| 07/07/2004 | CN1156282C 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 07/07/2004 | CN1156227C Mixed sodium peroxide solution containing sodium ozonide and its prepn. and application |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759515 A prostate-specific protein, and to polynucleotides encoding such polypeptides |
| 07/06/2004 | US6759242 Low oxygen culturing of neural crest stem cells and methods of use |
| 07/06/2004 | US6759239 Reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor cd8+cd28- t cells |
| 07/06/2004 | US6759229 Contacting a bacterial cell lysogenic for the selected bacteriophage genome with the isolated nucleic acid molecule such that the isolated nucleic acid is introduced into the bacterial cell; allowing it to recombine with genome |
| 07/06/2004 | US6759211 For cancer use in therapy |
| 07/06/2004 | US6759188 Method for producing interleukin 1 receptor antagonists, a therapeutic activity protein, from body fluids |
| 07/06/2004 | US6759058 Enteric-coated proliposomal formulations for poorly water soluble drugs |
| 07/06/2004 | US6759046 Peptides |
| 07/06/2004 | US6759037 Compositions and methods for treating diabetes |
| 07/06/2004 | US6759036 Fibrocyte-base vaccine formulations |
| 07/06/2004 | US6759035 Method to prevent graft rejection using TGF-beta to induce T suppressor cells |
| 07/06/2004 | US6758828 Catheter for cell delivery in tissue |
| 07/06/2004 | US6758673 Periosteal distraction |
| 07/06/2004 | CA2278759C Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 07/01/2004 | WO2004055217A1 Methods of determining embryo viability |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004054613A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |